ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,098, issued on July 7, was assigned to Yeda Research and Development Co. Ltd. (Rehovot, Israel).
"Methods and compositions for treating coronaviral infections" was invented by Gideon Schreiber (Rehovot, Israel), Jiri Zahradnik (Rehovot, Israel) and Yinon Rudich (Rehovot, Israel).
According to the abstract* released by the U.S. Patent & Trademark Office: "A polypeptide comprising an amino acid sequence of SARS COV-2 receptor-binding domain (RBD) is disclosed, wherein said amino acid sequence comprises a modification at position 358 and at least two additional modifications at two positions selected from the group consisting of 484, 498 and 501, wherein the polypeptide binds soluble...